Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
Clin Microbiol Infect. 2014 Oct;20(10):O600-8. doi: 10.1111/1469-0691.12478. Epub 2014 Apr 3.
We aimed to provide data on the diagnosis of tuberculous meningitis (TBM) in this largest case series ever reported. The Haydarpasa-1 study involved patients with microbiologically confirmed TBM in Albania, Croatia, Denmark, Egypt, France, Hungary, Iraq, Italy, Macedonia, Romania, Serbia, Slovenia, Syria and Turkey between 2000 and 2012. A positive culture, PCR or Ehrlich-Ziehl-Neelsen staining (EZNs) from the cerebrospinal fluid (CSF) was mandatory for inclusion of meningitis patients. A total of 506 TBM patients were included. The sensitivities of the tests were as follows: interferon-γ release assay (Quantiferon TB gold in tube) 90.2%, automated culture systems (ACS) 81.8%, Löwenstein Jensen medium (L-J) 72.7%, adenosine deaminase (ADA) 29.9% and EZNs 27.3%. CSF-ACS was superior to CSF L-J culture and CSF-PCR (p <0.05 for both). Accordingly, CSF L-J culture was superior to CSF-PCR (p <0.05). Combination of L-J and ACS was superior to using these tests alone (p <0.05). There were poor and inverse agreements between EZNs and L-J culture (κ = -0.189); ACS and L-J culture (κ = -0.172) (p <0.05 for both). Fair and inverse agreement was detected for CSF-ADA and CSF-PCR (κ = -0.299, p <0.05). Diagnostic accuracy of TBM was increased when both ACS and L-J cultures were used together. Non-culture tests contributed to TBM diagnosis to a degree. However, due to the delays in the diagnosis with any of the cultures, combined use of non-culture tests appears to contribute early diagnosis. Hence, the diagnostic approach to TBM should be individualized according to the technical capacities of medical institutions particularly in those with poor resources.
我们旨在提供有史以来最大的一组病例系列中关于结核性脑膜炎(TBM)诊断的数据。Haydarpasa-1 研究涉及 2000 年至 2012 年间在阿尔巴尼亚、克罗地亚、丹麦、埃及、法国、匈牙利、伊拉克、意大利、马其顿、罗马尼亚、塞尔维亚、斯洛文尼亚、叙利亚和土耳其确诊为 TBM 的患者。脑脊液(CSF)中培养物、PCR 或爱氏染色(EZNs)阳性是纳入脑膜炎患者的必要条件。共有 506 名 TBM 患者被纳入研究。测试的敏感性如下:干扰素-γ释放测定(Quantiferon TB gold in tube)90.2%、自动培养系统(ACS)81.8%、 Löwenstein Jensen 培养基(L-J)72.7%、腺苷脱氨酶(ADA)29.9%和 EZNs 27.3%。CSF-ACS 优于 CSF L-J 培养和 CSF-PCR(两者均为 p<0.05)。因此,CSF L-J 培养优于 CSF-PCR(p<0.05)。L-J 和 ACS 联合使用优于单独使用这些检测方法(p<0.05)。EZNs 和 L-J 培养之间的一致性较差,且呈负相关(κ=-0.189);ACS 和 L-J 培养之间的一致性较差,且呈负相关(κ=-0.172)(两者均为 p<0.05)。CSF-ADA 和 CSF-PCR 之间的一致性为中度,且呈负相关(κ=-0.299,p<0.05)。当联合使用 ACS 和 L-J 培养时,TBM 的诊断准确性提高。非培养检测在一定程度上有助于 TBM 的诊断。然而,由于任何一种培养方法都存在诊断延迟,因此联合使用非培养检测方法似乎有助于早期诊断。因此,TBM 的诊断方法应根据医疗机构的技术能力进行个体化,特别是在资源匮乏的医疗机构。